These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 8201847

  • 1. TCV-116, a newly developed angiotensin II receptor antagonist, induces regression of cardiac hypertrophy through suppression of the tissue renin-angiotensin system in spontaneously hypertensive rats.
    Mizuno K, Niimura S, Katoh K, Fukuchi S.
    Life Sci; 1994; 54(25):1987-94. PubMed ID: 8201847
    [Abstract] [Full Text] [Related]

  • 2. Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on cardiac hypertrophy and the tissue angiotensin II content in spontaneously hypertensive rats.
    Mizuno K, Tani M, Hashimoto S, Niimura S, Sanada H, Watanabe H, Ohtsuki M, Fukuchi S.
    Life Sci; 1992; 51(5):367-74. PubMed ID: 1385640
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
    Kojima M, Shiojima I, Yamazaki T, Komuro I, Zou Z, Wang Y, Mizuno T, Ueki K, Tobe K, Kadowaki T.
    Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
    [Abstract] [Full Text] [Related]

  • 4. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats.
    Takeda K, Fujita H, Nakamura K, Uchida A, Tanaka M, Itoh H, Nakata T, Sasaki S, Nakagawa M.
    Blood Press Suppl; 1994 May; 5():94-8. PubMed ID: 7889211
    [Abstract] [Full Text] [Related]

  • 5. Hypotensive activity of TCV-116, a newly developed angiotensin II receptor antagonist, in spontaneously hypertensive rats.
    Mizuno K, Niimura S, Tani M, Saito I, Sanada H, Takahashi M, Okazaki K, Yamaguchi M, Fukuchi S.
    Life Sci; 1992 May; 51(20):PL183-7. PubMed ID: 1435062
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparable effects of angiotensin II and converting enzyme blockade on hemodynamics and cardiac hypertrophy in spontaneously hypertensive rats.
    Mori T, Nishimura H, Ueyama M, Kubota J, Kawamura K.
    Jpn Circ J; 1995 Sep; 59(9):624-30. PubMed ID: 7500546
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B.
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [Abstract] [Full Text] [Related]

  • 12. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
    Paull JR, Widdop RE.
    J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
    [Abstract] [Full Text] [Related]

  • 13. Angiotensin II enhances integrin and alpha-actinin expression in adult rat cardiac fibroblasts.
    Kawano H, Cody RJ, Graf K, Goetze S, Kawano Y, Schnee J, Law RE, Hsueh WA.
    Hypertension; 2000 Jan; 35(1 Pt 2):273-9. PubMed ID: 10642310
    [Abstract] [Full Text] [Related]

  • 14. Effects of losartan, an angiotensin II antagonist, on the development of cardiac hypertrophy due to volume overload.
    Ishiye M, Umemura K, Uematsu T, Nakashima M.
    Biol Pharm Bull; 1995 May; 18(5):700-4. PubMed ID: 7492986
    [Abstract] [Full Text] [Related]

  • 15. The role of activated vascular angiotensin II generation in vascular hypertrophy in one-kidney, one clip hypertensive rats.
    Yu H, Rakugi H, Higaki J, Morishita R, Mikami H, Ogihara T.
    J Hypertens; 1993 Dec; 11(12):1347-55. PubMed ID: 8133017
    [Abstract] [Full Text] [Related]

  • 16. Role of angiotensin II in high fructose-induced left ventricular hypertrophy in rats.
    Kobayashi R, Nagano M, Nakamura F, Higaki J, Fujioka Y, Ikegami H, Mikami H, Kawaguchi N, Onishi S, Ogihara T.
    Hypertension; 1993 Jun; 21(6 Pt 2):1051-5. PubMed ID: 8505091
    [Abstract] [Full Text] [Related]

  • 17. Antihypertensive and hormonal activity of MK 954 in spontaneously hypertensive rats.
    Mizuno K, Niimura S, Tani M, Haga H, Gomibuchi T, Sanada H, Fukuchi S.
    Eur J Pharmacol; 1992 May 14; 215(2-3):305-8. PubMed ID: 1396995
    [Abstract] [Full Text] [Related]

  • 18. Comparative effects of three sites of renin-angiotensin blockade on the regression of left ventricular hypertrophy in spontaneously hypertensive rats.
    Zhang Q, Kohara K, Qui HY, Hiwada K.
    Am J Ther; 1997 May 14; 4(5-6):199-202. PubMed ID: 10423611
    [Abstract] [Full Text] [Related]

  • 19. Involvement of the renin-angiotensin system in the development of left ventricular hypertrophy and dysfunction.
    Yamazaki T, Shiojima I, Komuro I, Nagai R, Yazaki Y.
    J Hypertens Suppl; 1994 Nov 14; 12(9):S23-7. PubMed ID: 7884580
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin II receptor antagonist, TCV-116, prevents myocardial hypertrophy in spontaneously hypertensive rats.
    Kagoshima T, Masuda J, Sutani T, Sakaguchi Y, Tsuchihashi M, Tsuruta S, Iwano M, Dohi K, Nakamura Y, Konishi N.
    Blood Press Suppl; 1994 Nov 14; 5():89-93. PubMed ID: 7889210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.